Wilson N J, Barratt M, Jorgensen M, Limbu B, Donley M, Buchholtz M, Smith V, Deb S
School of Nursing and Midwifery, Western Sydney University, Hawkesbury Campus, Richmond, NSW, Australia.
Practice Quality Division, NDIS Quality and Safeguards Commission, Parramatta, NSW, Australia.
J Intellect Disabil Res. 2023 Jun;67(6):519-530. doi: 10.1111/jir.13023. Epub 2023 Mar 7.
There is evidence that psychotropic medications are overprescribed and overused to manage behaviours of concern for people with intellectual disabilities. Disability support workers and support staff lack education and training on the administration and safety of psychotropic medication use. This study aimed to test the applicability and preliminary efficacy of SPECTROM, an education programme developed in the UK, in an Australian context.
The training comprises two parts: Module 1 encompasses psychotropic medications, their use and side effects. Module 2 focuses on non-pharmacological interventions for supporting people with behaviours of concern. Thirty-three participants attended the training course and completed pre-training and post-training surveys on the Psychotropic Knowledge Questionnaire and Management of Aggression and Violence Attitude Scale-Revised at four time points: pre-training, 2 weeks, 3 months and 5 months post-training.
Psychotropic Knowledge Questionnaire scores showed statistically significant post-training improvement at all post-training time points (P < 0.05). Management of Aggression and Violence Attitude Scale-Revised scores were high at pre-training and did not change significantly at any of the post-training survey time points. A 2-week post-training feedback questionnaire reported 80% agreement that the training programme was appropriate, useful and valid. Only 36% of participants completed questionnaires at all time points.
SPECTROM training increased staff knowledge of psychotropic medications, yet loss of participants was high. Further refinement of the applicability of the training for the Australian context and evaluation of the feasibility of implementation, clinical and cost-effectiveness of the programme are required.
有证据表明，精神药物被过度开处方和使用，以管理智障人士令人担忧的行为。残疾支持工作者和辅助人员缺乏关于精神药物使用管理和安全性的教育与培训。本研究旨在测试英国开发的教育项目SPECTROM在澳大利亚背景下的适用性和初步疗效。
培训包括两个部分：模块1涵盖精神药物、其使用和副作用。模块2侧重于支持有令人担忧行为的人的非药物干预措施。33名参与者参加了培训课程，并在四个时间点（培训前、培训后2周、3个月和5个月）完成了关于精神药物知识问卷和攻击与暴力管理态度量表修订版的培训前和培训后调查。
精神药物知识问卷得分在所有培训后时间点均显示出培训后有统计学意义的提高（P<0.05）。攻击与暴力管理态度量表修订版得分在培训前较高，在任何培训后调查时间点均无显著变化。一份培训后2周的反馈问卷显示，80%的人认为培训项目合适、有用且有效。只有36%的参与者在所有时间点都完成了问卷。
SPECTROM培训增加了工作人员对精神药物的知识，但参与者流失率较高。需要进一步完善该培训在澳大利亚背景下的适用性，并评估该项目实施的可行性、临床效果和成本效益。
